Progentec Diagnostics

About:

Progentec is engaged in state of the art diagnostic interventions in therapeutic areas with a high level of unmet need.

Website: http://www.progentec.com

Twitter/X: progentecdx

Top Investors: Stanford University, i2E, OCA Ventures, Oklahoma Seed Capital Fund, NMC Health

Description:

Progentec Diagnostics was set up to explore and commercialize state of the art diagnostic interventions in therapeutic areas with a high level of unmet need. The company is collaborating with a number of research institutions and individuals around the world engaged in bringing the latest technological innovations to the field of diagnostics. The commitment to this cause is firmly rooted in our belief that better diagnostics would not only help in better and less costly management of diseases, but also help tremendously in reducing the incidence of diseases through early screening and detection.

Total Funding Amount:

$6.25M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oklahoma City, Oklahoma, United States

Founded Date:

2015-07-21

Contact Email:

mpurushothaman(AT)progentec.com

Founders:

Mohan Purushothaman

Number of Employees:

1-10

Last Funding Date:

2020-01-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai